Evaluation of chitosan/alginate beads using experimental design: Formulation and in vitro characterization

AAPS PharmSciTech

Volumn 11, Issue 1, 2010, Pages 460-466

  Takka, Sevgi ^a   Gürel, Aybige ^b  

^a GAZI UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

Alginate; Chitosan; Drug release; Encapsulation efficiency; Particle size

Indexed keywords

ALGINIC ACID; BOVINE SERUM ALBUMIN; CALCIUM CHLORIDE; CHITOSAN;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; GELATION; IN VITRO STUDY; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ALGINATES; ANIMALS; CALCIUM CHLORIDE; CATTLE; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DOSAGE FORMS; GLUCURONIC ACID; HEXURONIC ACIDS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; SERUM ALBUMIN, BOVINE;

EID: 77950868738     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9406-z     Document Type: Article

References (24)

1. S Hwang H Park K Park 1998 Gastric retentive drug delivery systems Crit Rev Ther Drug Carr Syst 15 243 284
2. Lee VH, Grass GM, Dodda-Kashi S, Rubas W. Oral route of peptide and protein drug delivery. In: Lee VH, editor. peptide and protein drug delivery. New York: Marcel & Dekker; 1991. p. 691-741.
3. Ingemann M, Frokjaer S, Hovgaard L. Peptide and protein drug delivery systems for non-parenteral routes of administration. In: Frokjaer S, Hovgaard L, editors. Pharmaceutical formulation development of peptides and proteins. Philadelphia: Taylor & Francis; 2000. p. 189-203.
4. M George TE Abraham 2006 Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review J Cont Rel 114 1 14 10.1016/j.jconrel.2006.04.017 1:CAS:528:DC%2BD28XnsFCrsbg%3D (Pubitemid 44131680)
5. WR Gombotz SF Wee 1998 Protein release from alginate matrices Adv Drug Deliv Rev 31 267 285 10.1016/S0169-409X(97)00124-5 1:CAS:528:DyaK1cXhvVSjsLc%3D 10837629 (Pubitemid 28191869)
6. HH Tonnesen J Karlsen 2002 Alginate in drug delivery Drug Dev Ind Pharm 28 621 630 10.1081/DDC-120003853 1:CAS:528:DC%2BD38Xls1Onsb0%3D 12149954 (Pubitemid 34809561)
7. S Takka F Acartürk 1999 Calcium alginate microparticles for oral administration: I. Effect of sodium alginate type on drug release and drug entrapment efficiency J Microencapsul 16 275 290 10.1080/026520499289022 1:CAS:528:DyaK1MXivVeltL4%3D 10340214 (Pubitemid 29191812)
8. C Aral J Akbuǧa 1998 Alternative approach to the preparation of chitosan beads Int J Pharm Sci 168 9 15 10.1016/S0378-5173(98)00072-6 1:CAS:528:DyaK1cXktVOgsr8%3D (Pubitemid 28293658)
9. S Şenel AA HIncal 2001 Drug permeation enhencement via buccal route: possibilities and limitations J Contr Rel 72 133 144 10.1016/S0168- 3659(01)00269-3 (Pubitemid 32522351)
10. G Coppi V Iannuccelli E Leo MT Bernabei R Cameroni 2001 Chitosan-alginate microparticles as a protein carrier Drug Dev Ind Pharm 27 393 400 10.1081/DDC-100104314 1:CAS:528:DC%2BD3MXltVKntbg%3D 11448046 (Pubitemid 32612728)
11. KL Douglas M Tabriziani 2005 Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier J Biomater Sci Polym ed 16 43 56 10.1163/ 1568562052843339 1:CAS:528:DC%2BD2MXis1Gjt74%3D 15796304 (Pubitemid 41149195)
12. A Polk B Amsden K De Yao T Peng MFA Goosen 1994 Controlled release of albumin from chitosan alginate microcapsules J Pharm Sci 83 178 185 10.1002/jps.2600830213 1:CAS:528:DyaK2cXmt1Witg%3D%3D 8169785 (Pubitemid 24224173)
13. L Zhang J Guo X Peng Y Jin 2004 Preparation and release behavior of carboxymethylated chitosan/alginate microspheres encapsulating bovine serum albumin J Appl Polym Sci 92 878 882 10.1002/app.13708 1:CAS:528: DC%2BD2cXitVWlsrc%3D (Pubitemid 38395237)
14. PR Hari T Chandy CP Sharma 1996 Chitosan/calcium alginate beads for oral delivery of insulin J Appl Polym Sci 59 1795 1801 10.1002/(SICI)1097- 4628(19960314)59:11<1795::AID-APP16>3.0.CO;2-T 1:CAS:528: DyaK28XhtFaquro%3D (Pubitemid 126581518)
15. GW Vandenberg L De La Noüe 2001 Evaluation of protein release from chitosan-alginate microcapsules produced using external or internal gelation J Microencapsul 18 433 441 10.1080/02652040010019578 1:CAS:528: DC%2BD3MXksVOmt74%3D 11428673 (Pubitemid 32577119)
16. C Narendera MS Srinath B Prakash Rao 2005 Development of three layered buccal compact containing metoprolol tartrate by statistical optimization technique Int J Pharm 304 102 114 10.1016/j.ijpharm.2005.07.021 (Pubitemid 41427654)
17. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the folin phenol reagent J Biol Chem 193 265 275 1:CAS:528:DyaG38XhsVyrsw%3D%3D 14907713
18. S Takka Ö Ocak F Acartürk 1998 Calcium alginate microparticles for oral administration: II. Effect of formulation factors on drug release and drug entrapment efficieny Eur J Pharm Sci 6 241 266 10.1016/S0928-0987(97)10005- 7 1:CAS:528:DyaK1cXjt1Cmt7w%3D 9795073 (Pubitemid 28473225)
19. FL Mi HW Sung SS Shyu 2002 Drug release from chitosan-alginate complex beads reinforced by a naturally occurring cross-linking agent Carbohyd Polym 48 61 72 10.1016/S0144-8617(01)00212-0 1:CAS:528:DC%2BD38Xhs1Sn (Pubitemid 33149550)
20. O Gåserød A Sannes G Skjak-Braek 1999 Microcapsules of alginate-chitosan. II. A study of capsule stability and permeability Biomaterials 20 773 783 10.1016/S0142-9612(98)00230-0 10353660 (Pubitemid 29176706)
21. T Takahashi K Takayama Y Machida T Nagai 1990 Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate Int J Pharm 61 35 41 10.1016/0378-5173(90)90041-2 1:CAS:528:DyaK3cXltVegs7k%3D (Pubitemid 20201603)
22. T Gazori MR Khoshayand E Azizi P Yazdizade 2009 Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: formulation, optimaztion and in vitro characterization Carbohydr Polym 77 599 606 10.1016/j.carbpol.2009.02.019 1:CAS:528:DC%2BD1MXmtVeqtrc%3D
23. SK Motwari S Chopra S Talegaonkar K Kohli FJ Ahmad RK Khar 2008 Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation Eur J Pharm Biopharm 68 513 525 (Pubitemid 351318222)
24. Lewis GA, Luu RP, Mathiey D. Pharmaceutical experimental design. New York: Marcel Dekker; 1999.